September 2009 – Policy & Medicine

Health Care Reform: Senate Finance Committee Rejects Public Option

FDA Hires IOM to Review Medical Device Approval System

FDA Hearing on Internet and Web 2.0

Health Care Reform: Nelson Amendments to End Deal with Pharmaceutical Companies Voted Down

Physician Payment Sunshine: Lilly’s Disclosure Used Against Massachusetts Physicians

ACCME Bans Corporate Scientists From Presenting Translational Research at CME Events

Conferences: Fourth Annual FDA Regulatory Symposium

Letters from Grassley: Are Statins Safe? Is the Sky Blue?

Health Care Reform: Harvard Dean Rethinking Reform

The Five Misleading Words of Health Care Reform